| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 119.80M | 90.50M | 73.70M | 75.00M | 75.50M | 146.30M |
| Gross Profit | 63.30M | 56.20M | 46.40M | 47.10M | 49.20M | 90.70M |
| EBITDA | 44.40M | 44.80M | 37.80M | 37.50M | 34.60M | 68.10M |
| Net Income | 29.90M | 23.70M | -16.80M | 7.00M | -122.10M | -121.10M |
Balance Sheet | ||||||
| Total Assets | 1.02B | 1.05B | 781.50M | 819.10M | 1.23B | 1.38B |
| Cash, Cash Equivalents and Short-Term Investments | 88.60M | 61.30M | 108.60M | 82.80M | 150.50M | 80.80M |
| Total Debt | 510.50M | 510.60M | 373.40M | 371.50M | 715.30M | 714.90M |
| Total Liabilities | 565.80M | 564.00M | 402.90M | 405.00M | 765.50M | 767.70M |
| Stockholders Equity | 450.90M | 490.10M | 378.60M | 414.10M | 460.40M | 610.60M |
Cash Flow | ||||||
| Free Cash Flow | 27.50M | 18.70M | 24.00M | 34.90M | -4.40M | 21.40M |
| Operating Cash Flow | 30.70M | 28.40M | 27.00M | 47.50M | 8.90M | 45.60M |
| Investing Cash Flow | 400.00K | -67.80M | 18.80M | 239.80M | 62.90M | -40.50M |
| Financing Cash Flow | -126.90M | -32.10M | -20.00M | -355.00M | -2.10M | 48.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £1.00B | 6.99 | 5.54% | 7.70% | 7.57% | ― | |
72 Outperform | £401.64M | 3.34 | 11.57% | 7.17% | 1.60% | 211.81% | |
71 Outperform | £309.66M | 5.78 | 6.35% | 9.66% | 84.02% | 53.97% | |
71 Outperform | £157.72M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
69 Neutral | £1.61B | 7.17 | 11.77% | 4.33% | 16.30% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £279.36M | 90.71 | 0.80% | 8.16% | -4.24% | -273.62% |